Both in Pharmaceuticals
Journey Medical vs Foghorn Therapeutics
Over the past year DERM returned −45.5% and FHTX returned −49.4%; their daily moves had a correlation of 0.18.
DERM −45.5% FHTX −49.4%Growth of $1, one year, split-adjusted
| Metric | DERM | FHTX |
|---|---|---|
| Price | $4.64 | $2.13 |
| Market cap | $131.0M | $126.5M |
| Today | −3.13% | 0.00% |
| 1 month | −30.6% | +6.5% |
| 6 months | −10.4% | −54.1% |
| Year to date | −39.8% | −60.6% |
| 1 year | −42.9% | −51.7% |
| Revenue growth (YoY) | +18.9% | +112.7% |
| Gross margin | 65.6% | 100.0% |
| Net margin | −1.7% | −44.7% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 3.4× |
| Net cash | -$245.0K | $167.6M |
| Dividend yield | — | — |
| Volatility (60d) | 64.3% | 99.1% |
| Short % of float | 24.8% | 7.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).